These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24333406)

  • 1. Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.
    Polk BI; Becker ML
    Discov Med; 2013 Dec; 16(90):267-75. PubMed ID: 24333406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in pediatric rheumatology.
    Becker ML
    Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics in rheumatology: the prospects and limitations of an emerging field.
    Siva C; Yokoyama WM; McLeod HL
    Rheumatology (Oxford); 2002 Nov; 41(11):1273-9. PubMed ID: 12422000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
    Ferraccioli G; De Santis M; Tolusso B
    Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics: implications for therapy in rheumatic diseases.
    Davila L; Ranganathan P
    Nat Rev Rheumatol; 2011 Aug; 7(9):537-50. PubMed ID: 21826093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision Medicine: Towards Individualized Dosing in Pediatric Rheumatology.
    Balevic SJ; Sagcal-Gironella ACP
    Rheum Dis Clin North Am; 2022 Feb; 48(1):305-330. PubMed ID: 34798954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
    Seidman EG; Furst DE
    J Rheumatol; 2002 Dec; 29(12):2484-7. PubMed ID: 12465139
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetic of antirheumatic treatments: clinical implications.
    Ferraccioli G; Tolusso B; De Santis M
    Pharmacogenomics J; 2007 Feb; 7(1):2-9. PubMed ID: 16702980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible clinical application of pharmacogenetics in rheumatology.
    Ferraccioli G
    J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture.
    Cronstein BN
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):2-3. PubMed ID: 16932642
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
    Umićević Mirkov M; Coenen MJ
    Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug response.
    Asanuma Y; Xie HG; Stein CM
    Arthritis Rheum; 2005 May; 52(5):1349-59. PubMed ID: 15880820
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii25-ii27. PubMed ID: 15479867
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in pharmacogenomics of pediatric rheumatic diseases].
    Wei QJ; Song HM
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):725-729. PubMed ID: 31530364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
    Tavakolpour S; Darvishi M; Ghasemiadl M
    Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy.
    Calabrese C
    Med Clin North Am; 2021 Mar; 105(2):213-225. PubMed ID: 33589098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
    Ruperto N; Martini A
    Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
    Taniguchi A; Urano W; Tanaka E; Kamatani N
    Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personalized medicine in rheumatology].
    Szekanecz Z
    Orv Hetil; 2013 Mar; 154(13):483-96. PubMed ID: 23524232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.